ORIX USA ABOUT US BUSINESSES PROVEN SUCCESS NEWS CAREERS SUSTAINABILITY & SOCIAL RESPONSIBILITY CONTACT GROWTH CAPITAL For leading technology companies, growth is critical—and capital is essential. Our Growth Capital and Venture Debt team provides highly customized equity and debt solutions to help take your company to the next level. Our flexibility, relationship approach, sector expertise, deep pockets and long-term focus make us an ideal partner for high-growth companies. Since 2001, we’ve funded over $1.6 billion to more than 155 companies, learning each business from the inside out and crafting deals with the financing levels, terms and timing to fund strategic progress. PARTNERS IN GROWTH As your capital needs continue to grow, Growth Capital grows along with you. We invest across the balance sheet, including first lien unitranche, second lien facilities behind bank capital, and equity co-investments. We are enterprise value lenders who can make investments from $5 million all the way to $50 million. Our investments provide a compelling mix of cost of capital and flexibility to support growth companies. We offer a variety of debt structures and equity co-investments that can be modified over time to adapt to changing business realities. Our specialties range from senior secured to junior lien to equity, and typically include extended interest-only periods, flexible amortization schedules and delayed draw capabilities with maturities between three to five years. Importantly, we bring the same level of attention, enthusiasm and creativity to every transaction—no matter the size. OUR INVESTMENT CRITERIA While each of our portfolio companies has its own unique needs, the majority of our clients share some common characteristics: Growth companies primarily in the technology sector Mid- to late-stage growth companies with strong customer validation Run-rate revenues of $10 million or greater with good top line growth and revenue visibility A proven management team with a clear vision for success The ability to reasonably project forecasted product and/or service demand Support from a seasoned venture capital firm or growth-focused private equity sponsor A realistic path to break-even cash flow within 24 months of our investment Download the Growth Capital Overview OUR TEAM Jeffrey Bede Managing Director And Head Of ORIX Growth Capital William Bishop Managing Director David Orlandella Managing Director 214.237.2367 Abhishek Sud Managing Director 646.673.6999 Stasia Carson Director 703.647.4140 Laura Johnson Director 628.867.1623 Blake Zhang Director 612.859.1233 Harry Wong Associate Director 425.440.2506 Alexander Pallesen Senior Associate 628.867.1624 Nick Contreras Associate 469.799.1537 Mehul Mittal Analyst 913.991.0443 Sneh Patel Analyst 601.392.3200 Ankur Shiwakoti Analyst 972.799.1780 Deborah Blake Administrative Assistant 214.237.2028 GROWTH CAPITAL NEWSROOM Village Fertility Secures $12M in Debt Financing from... OCT 20 2021 VFP Pharmacy Group (“Village”, “VFP”, or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a healthcare private equity firm based... READ MORE Betterment Raises $160 Million in Growth Capital... SEP 29 2021 Betterment, the largest independent digital investment advisor with $32 billion in assets under management and nearly 700,000 clients, announced today that it has secured $160 million in... READ MORE DrChrono Raises $12M from ORIX Corporation USA’s Growth... JUN 23 2021 DrChrono Inc., a company developing an essential platform and services for modern medical practices, today announced it has raised a new round of... READ MORE ORIX CORPORATION USA 280 Park Avenue, 40th Floor West New York, NY 10017 212.468.5888 2001 Ross Avenue, Suite 1900 Dallas, TX 75201 214.237.2000 COMPANY ABOUT US BUSINESSES PROVEN SUCCESS NEWS CAREERS SUSTAINABILITY & SOCIAL RESPONSIBILITY CONTACT CONTACT US Copyright 2014 ORIX USA Privacy Policy | Legal Information